Frontlight ResearchEarly access
Glioblastoma trials in United States
199 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleTear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Patients
- Where
- Duarte
- Age
- 18 years and over
- People
- 30
- Run by
- City of Hope Medical Center
See details and how to joinNCT07775534 - Phase 1/2Taking peopleA Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Where
- Chicago, Dallas, Houston, New York, Salt Lake City, San Antonio, Seattle
- Age
- 18 years and over
- People
- 116 worldwide
- Run by
- Debiopharm International SA
See details and how to joinNCT05765812 · EU 2022-502156-31-00 - No phaseNot yet taking people in United StatesGLAD-KE GLioma Biomarker and Safety Assessment During Dietary Ketone Elevation Subtitle: A Surgical Biomarker Discovery Study of Ketogenic Therapy in Recurrent Glioma
- Where
- Baltimore
- Age
- 18 years to 111 years
- People
- 20
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07852975 - Phase 1Enrolling by invitationIntrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
- Where
- Iowa City
- Age
- 13 years and over
- People
- 34
- Run by
- Andrew P. Groves
See details and how to joinNCT06896110 - Phase 2Taking peopleTemozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 60
- Run by
- Mayo Clinic
See details and how to joinNCT07708961 - Phase 1/2Taking peopleStudy of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
- Where
- Columbus
- Age
- 18 years to 70 years
- People
- 68 worldwide
- Run by
- Trogenix ltd
See details and how to joinNCT07346144 - Phase 1Taking peopleLocoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
- Where
- Duarte
- Age
- 18 years and over
- People
- 24
- Run by
- City of Hope Medical Center
See details and how to joinNCT07544992 - Phase 1Taking peopleIntracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
- Where
- Duarte
- Age
- 18 years and over
- People
- 27
- Run by
- City of Hope Medical Center
See details and how to joinNCT06815029 - Early phase 1Taking peopleImplantable Microdevice In Primary Brain Tumors
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Oliver Jonas
See details and how to joinNCT04135807 - Phase 1Taking peopleSafety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
- Where
- San Antonio
- Age
- 18 years and over
- People
- 40
- Run by
- Cerenome
See details and how to joinNCT05460507 - Phase 1Taking peopleD2C7-IT + 2141-V11 Combination Post-resection in rGBM
- Where
- Durham
- Age
- 18 years and over
- People
- 46
- Run by
- Darell Bigner
See details and how to joinNCT06455605 - Phase 1/2Taking peopleSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Where
- Boston, Chicago, Columbus, Fairfax, Houston, Irvine, Jacksonville, Los Angeles, New York, Rochester, Salt Lake City, San Francisco, Scottsdale, Washington D.C.
- Age
- 18 years and over
- People
- 191
- Run by
- Tango Therapeutics, Inc.
See details and how to joinNCT06810544 - Phase 1Taking peopleTesting the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Where
- Atlanta, Charlotte, Chicago, City of Saint Peters, Columbus, Coral Gables, Coral Springs, Creve Coeur, Deerfield Beach, Doral, Duarte, Fairway, Hollywood, Irvine, Kansas City, La Jolla, Lexington, Madison, Miami, Mineola, Nashville, New Haven, New York, North Miami, Oklahoma City, Orange, Pittsburgh, Plantation, Richmond, Sacramento, Salt Lake City, Shiloh, St Louis, Trumbull, Washington D.C., Westwood, Winston-Salem
- Age
- 18 years and over
- People
- 30
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06860594 - Phase 1Taking peopleA Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.
- Where
- Duarte, Fairfax, Houston, Tampa
- Age
- 18 years and over
- People
- 120
- Run by
- Crossbow Therapeutics, Inc.
See details and how to joinNCT07779798 - Phase 2Not yet taking people in United StatesLaser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
- Where
- Rochester, St Louis
- Age
- 18 years and over
- People
- 99
- Run by
- Washington University School of Medicine
See details and how to joinNCT07620548 - Early phase 1Taking peopleWindow of Opportunity Study of Lixumistat in Patients With Newly Diagnosed Glioblastoma
- Where
- Miami
- Age
- 18 years and over
- People
- 10
- Run by
- Macarena De La Fuente, MD
See details and how to joinNCT07884344 - Phase 3Taking peopleSIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Where
- Atlanta, Aurora, Billings, Birmingham, Boston, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Durham, Fairfax, Gainesville, Houston, Indianapolis, Jacksonville, Kansas City, La Jolla, Lexington, Los Angeles, Madison, Miami, Nashville, New Brunswick, New Haven, Newport Beach, New York, Orlando, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, Salt Lake City, San Antonio, San Francisco, Seattle, St Louis, Winston-Salem
- Age
- 18 years and over
- People
- 365 worldwide
- Run by
- Nuvation Bio Inc.
See details and how to joinNCT05303519 - Phase 1/2Taking peopleD2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
- Where
- Durham
- Age
- 18 years and over
- People
- 50
- Run by
- Darell Bigner
See details and how to joinNCT05734560 - Early phase 1Taking peopleA Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
- Where
- Chandler, Phoenix
- Age
- 18 years and over
- People
- 82
- Run by
- St. Joseph's Hospital and Medical Center, Phoenix
See details and how to joinNCT06072586 - Phase 1Taking peopleHypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 28
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06344130 - Phase 1/2Taking peopleNovel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
- Where
- Bethesda
- Age
- 18 years to 99 years
- People
- 40
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT07416188 - Early phase 1Taking peoplePilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
- Where
- Nashville
- Age
- 18 years and over
- People
- 30
- Run by
- Eben Rosenthal
See details and how to joinNCT07493447 - Phase 2Not yet taking people in United StatesThe GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
- Where
- Baltimore
- Age
- 18 years to 70 years
- People
- 40 worldwide
- Run by
- T-MAXIMUM Pharmaceutical Inc
See details and how to joinNCT07386002 - Phase 2Taking peoplePre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.
- Where
- Camden
- Age
- 18 years to 80 years
- People
- 70
- Run by
- Cooper Norcross Health
See details and how to joinNCT07439172 - Phase 1Taking peopleTMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma
- Where
- Buffalo
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Alpheus Medical, Inc.
See details and how to joinNCT07862647